Comments

Inventiva Stock Price, Quotes and Forecasts

Q: What sector and industry does Inventiva (IVA) operate in?

Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

IVANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

FY 2024 Earnings were released on Wed Mar 26th, after the market close

The most recent conference call was at 8:00 AM, 1 day ago Click to view past webcast

Inventiva (IVA) Forecast

News Earnings Inventiva (IVA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Inventiva Stock Price, Quotes and Forecasts | NASDAQ:IVA | Benzinga

Explore Inventiva stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IVA.

Open	$3.01
Close	-
Volume / Avg.	2.54K / 9.44K
Day Range	$2.89 - $3.01
52 Wk Range	1.53 - 3.98
Market Cap	$151.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	1.24%
Days to Cover	33.79

Recent News

Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?

Inventiva secures €94.1M in financing, potentially reaching €348M, to fund the Phase 3 NATiV3 trial for lanifibranor in NASH. Leadership changes include new chairman and director appointments.

Vandana Singh

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Gold Falls Over 1%; HilleVax Shares Plunge

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.01
Close	-
Volume / Avg.	2.54K / 9.44K
Day Range	$2.89 - $3.01
52 Wk Range	1.53 - 3.98
Market Cap	$151.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	1.24%
Days to Cover	33.79

About Inventiva

Sector

Health Care

Industry

Biotechnology

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Inventiva (IVA) stock?

You can purchase shares of Inventiva (NASDAQ:IVA) through any online brokerage.

View our list of the best stock brokerages

Who are Inventiva (IVA) competitors?

Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Korro Bio (NASDAQ:KRRO).

What is the forecast, or price target, for Inventiva (IVA) stock?

Inventiva has a consensus price target of $12.67.

What is the current price for Inventiva (IVA)?

The stock price for Inventiva (NASDAQ: IVA) is $2.9 last updated March 28, 2025 at 12:39 PM EDT.

Does Inventiva (IVA) pay a dividend?

There are no upcoming dividends for Inventiva.

When is Inventiva (NASDAQ:IVA) reporting earnings?

Inventiva’s FY earnings are confirmed for Wednesday, March 26, 2025.

Is Inventiva (IVA) going to split?

There is no upcoming split for Inventiva.

What sector and industry does Inventiva (IVA) operate in?

Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.